Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - live canine parvovirus strain nl-35-d - solution for injection - . - canine parvovirus - dogs - immunological - live vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - live canine parvovirus strain nl-35-d; inactivated leptospira canicola; inactivated leptospira icterohaemorrhagiae - solution for injection - . - live canine parvovirus + inactivated leptospira - dogs - immunological - mixed vaccine (l & a)

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - live canine parvovirus strain nl-35-d, leptospira canicola inactivated, leptospira icterohaemorrhagiae inactivated - solution for injection - %v/v - live canine parvovirus vaccine + inactivated leptospira vaccine - canine - immunological - mixed vaccine (live and inactivated)

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - live canine parvovirus strain nl-35-d - solution for injection - unknown - canine parvovirus vaccine - canine - immunological - live vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - canine distemper virus strain n-cdv (live, attenuated); canine adenovirus type 2 virus, strain manhattan (live, attenuated); canine parainfluenza type 5 virus, strain nl-cpi-5 (live, attenuated); canine parvovirus strain nl-35-d (live, attenuated); leptospira canicola inactivated ; leptospira icterohaemorrhagiae inactivated - lyophilisate and solvent for solution for injection - . - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira - dogs - immunological - mixed vaccine (l & a)

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - canine adenovirus type 2 strain manhattan - live; canine distemper virus strain onderstepoort; canine parvovirus strain 154 - live - parenteral liquid/solution/suspension - canine adenovirus type 2 strain manhattan - live vaccine-viral active 0.0 tcid50; canine distemper virus strain onderstepoort vaccine-viral active 0.0 tcid50; canine parvovirus strain 154 - live vaccine-viral active 0.0 tcid50 - immunotherapy - dog - with exclusions see label - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | infectious canine hepatitis | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - canine distemper virus, strain n-cdv; canine adenovirus type 2, strain manhattan; canine parvovirus, strain nl-35-d; gentamicin - misc. vaccines or anti sera - canine distemper virus, strain n-cdv vaccine-viral active 0.0 p; canine adenovirus type 2, strain manhattan vaccine-viral active 0.0 p; canine parvovirus, strain nl-35-d vaccine-viral active 0.0 p; gentamicin antibiotic other 30.0 ug/ml - immunotherapy

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - canine distemper virus strain n-cdv (live, attenuated), canine adenovirus type 2 virus, strain manhattan (live, attenuated), canine parainfluenza type 5 virus, strain nl-cpi-5 (live, attenuated), canine parvovirus, strain nl-35-d, live attenuated, leptospira icterohaemorrhagiae inactivated, leptospira canicola inactivated - lyophilisate and solvent for solution for injection - %v/v - live canine distemper virus vaccine + live canine adenovirus vaccine + live canine parainfluenza vi - canine - immunological - mixed vaccine (live and inactivated)

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - live attenuated canine distemper virus strain onderstepoort: 105.1 – 106.5 tcid50, live recombinant canine parvovirus strain 630a: 105.1 – 106.7 tcid50 - immunologicals for canidae - dogs (small) - for the active immunisation of puppies from 4 weeks of age onwards to prevent clinical signs and mortality of canine distemper virus infection and canine parvovirus infection and to prevent viral excretion following canine distemper virus infection and following canine parvovirus infection.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parainfluenza type 2; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parainfluenza type 2 vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | parvovirus